The addition of doxazosin to the treatment regimen of patients with hypertension not adequately controlled by beta-blockers

Am Heart J. 1991 Jan;121(1 Pt 2):311-6. doi: 10.1016/0002-8703(91)90864-e.

Abstract

When doxazosin was given to patients with hypertension not adequately controlled by beta-blockade, blood pressure was normalized in 94% of the 34 patients (blood pressure less than or equal to 140/85 mm Hg). This reduction in blood pressure was obtained with doxazosin in combination with metoprolol or oxprenolol at a mean final daily dose of 1.3 mg or pindolol or atenolol at 2.0 mg/day. Exercise-induced increase in systolic and diastolic blood pressure was also lower with combined beta-blocker and doxazosin therapy than with beta-blocker alone. After 12 weeks of treatment, the combination of doxazosin and beta-blocker significantly reduced total serum cholesterol and triglyceride levels. All side effects were mild and only one patient was withdrawn from therapy.

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use*
  • Antihypertensive Agents / administration & dosage
  • Antihypertensive Agents / therapeutic use*
  • Doxazosin
  • Drug Therapy, Combination
  • Female
  • Humans
  • Hypertension / drug therapy*
  • Lipids / blood
  • Male
  • Middle Aged
  • Prazosin / administration & dosage
  • Prazosin / analogs & derivatives*
  • Prazosin / therapeutic use
  • Time Factors

Substances

  • Adrenergic beta-Antagonists
  • Antihypertensive Agents
  • Lipids
  • Doxazosin
  • Prazosin